DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (15)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Epirubicin side effects in 57 year old female

Reported by a consumer/non-health professional from Spain on 2012-07-27

Patient: 57 year old female

Reactions: Pyrexia, Neutropenia, Hidradenitis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer
    Start date: 2006-08-23
    End date: 2006-11-02

Docetaxel
    Indication: Breast Cancer
    Start date: 2006-08-23
    End date: 2006-11-02

Other drugs received by patient: Hipoartel; Simvastatin; Ceftazidime; Pantoprazole



Possible Epirubicin side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20

Patient: 44 year old female, weighing 55.5 kg (122.1 pounds)

Reactions: Abdominal Pain, Intestinal Ischaemia, Colitis Ischaemic, White Blood Cell Count Decreased, Vomiting, Blood Creatine Phosphokinase Increased, Gastrointestinal Necrosis, Pyrexia, Multi-Organ Failure, Diarrhoea, GAS Gangrene, Heart Rate Increased, Bone Marrow Failure, Neutropenia, Clostridial Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 7 cycles, total 4 courses
    Indication: Breast Cancer
    Start date: 2011-07-22
    End date: 2011-09-22

Epirubicin
    Dosage: 7 cycles, total 4 courses
    Indication: Breast Cancer
    Start date: 2011-07-22
    End date: 2011-09-22

Taxotere
    Dosage: 4 cycles, total 3 courses, dose taken once daily
    Indication: Breast Cancer
    Start date: 2011-10-14
    End date: 2011-11-25

Other drugs received by patient: Leucon; Lorazepam; Decadron Phosphate; Lorazepam; Kytril; Prochlorperazine; Kytril; Cepharanthin; Decadron Phosphate; Marzulene S



Possible Epirubicin side effects in 68 year old female

Reported by a physician from Japan on 2012-06-15

Patient: 68 year old female, weighing 39.9 kg (87.8 pounds)

Reactions: White Blood Cell Count Decreased, Dyspnoea, Nausea, Hypotension, Tachycardia, Toxic Epidermal Necrolysis, Pyrexia, Haemoglobin Decreased, Respiratory Failure, Circulatory Collapse, Neutropenia, Rash Vesicular, Oxygen Saturation Decreased, Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-02-28

Epirubicin
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-02-28



Possible Epirubicin side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-13

Patient: 67 year old female

Reactions: Acute Myeloid Leukaemia, Pyrexia, Papule

Drug(s) suspected as cause:
Idarubicin HCL
    Dosage: (12 mg/m2)
    Indication: Acute Myeloid Leukaemia

Cyclophosphamide
    Dosage: (df), (df), (df), (df)
    Indication: Breast Cancer

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia

Trastuzumab (Trastuzumab)
    Dosage: (1 df 3x/week)
    Indication: Breast Cancer

Mitoxantrone
    Dosage: (7 mg/m2)
    Indication: Acute Myeloid Leukaemia

Epirubicin
    Dosage: (df), (df), (df), (df)
    Indication: Breast Cancer

Docetaxel
    Dosage: (df), (df), (df), (df)
    Indication: Breast Cancer

Fluorouracil
    Dosage: (df), (df), (df), (df)
    Indication: Breast Cancer

Tegafur Uracil (Tegafur / Uracil)
    Dosage: (df oral)
    Administration route: Oral
    Indication: Colon Cancer



Possible Epirubicin side effects in female

Reported by a physician from Germany on 2012-05-18

Patient: female, weighing 110.0 kg (242.0 pounds)

Reactions: Vomiting, Nasopharyngitis, Nausea, Diarrhoea, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: 200 mg, unk
    Start date: 2010-11-05
    End date: 2011-01-07

NO Treatment Received
    Dosage: no treatment
    Indication: Breast Cancer

Fluorouracil
    Dosage: 100 mg, unk
    Start date: 2010-11-05
    End date: 2011-01-07

Cyclophosphamide
    Dosage: 1000 mg, unk
    Start date: 2010-11-05
    End date: 2011-01-07

Other drugs received by patient: Paracodin Bitartrate TAB; Cefuroxime; Acetylcysteine; Allopurinol



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-18

Patient: 49 year old female

Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Multi-Organ Failure, Death, Lymphocytosis, Dizziness, Asthenia, Septic Shock, Leukocytosis, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytoxan
    Dosage: 100 mg, unk
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Epirubicin
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Fluorouracil
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-15

Patient: 49 year old female

Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Lymphocytosis, Multi-Organ Failure, Death, Dizziness, Septic Shock, Asthenia, Leukocytosis, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Fluorouracil
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Epirubicin
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01



Possible Epirubicin side effects in 68 year old female

Reported by a physician from Japan on 2012-05-04

Patient: 68 year old female, weighing 39.9 kg (87.8 pounds)

Reactions: White Blood Cell Count Decreased, Dyspnoea, Nausea, Hypotension, Tachycardia, Toxic Epidermal Necrolysis, Pyrexia, Haemoglobin Decreased, Respiratory Failure, Circulatory Collapse, Neutropenia, Rash Vesicular, Oxygen Saturation Decreased, Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-02-28

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-02-28



Possible Epirubicin side effects in male

Reported by a individual with unspecified qualification from Italy on 2012-04-04

Patient: male

Reactions: Caesarean Section, Ventricular Hypokinesia, Foetal Exposure During Pregnancy, Pyrexia, Klebsiella Test Positive, Staphylococcus Test Positive, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin



Possible Epirubicin side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-23

Patient: male

Reactions: Ventricular Hypokinesia, Foetal Exposure During Pregnancy, Pyrexia

Drug(s) suspected as cause:
Epirubicin



Possible Epirubicin side effects in female

Reported by a physician from Switzerland on 2012-03-02

Patient: female, weighing 41.0 kg (90.2 pounds)

Reactions: Febrile Neutropenia, Pyrexia, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: 75mgm2 cyclic
    Indication: Neoplasm
    Start date: 2010-04-27

Votrient
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2010-04-28

Other drugs received by patient: Dexamethasone; Dexamethasone



Possible Epirubicin side effects in 18 year old female

Reported by a physician from India on 2012-02-21

Patient: 18 year old female

Reactions: Enterococcal Bacteraemia, Encephalopathy, Pyrexia, Leukaemia Recurrent, B Precursor Type Acute Leukaemia, Venoocclusive Liver Disease, Sepsis, Tachypnoea, Pleural Effusion, Acute Hepatic Failure, Gallbladder Disorder

Drug(s) suspected as cause:
Vincristine
    Indication: Acute Lymphocytic Leukaemia

Elspar
    Indication: Acute Lymphocytic Leukaemia

Epirubicin
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Total Parenteral Nutrition (Tpn) (Tpn); Norethindrone



Possible Epirubicin side effects in 38 year old female

Reported by a individual with unspecified qualification from United States on 2012-01-27

Patient: 38 year old female

Reactions: Confusional State, Vomiting, Gastrointestinal Toxicity, Neurological Decompensation, Nausea, Oesophageal Fistula, FAT Embolism, Pyrexia, Haematemesis, Grand MAL Convulsion, Cerebral Artery Embolism, Brain Oedema, Intracranial Pressure Increased, Heart Injury, Gastrointestinal Injury

Adverse event resulted in: death

Drug(s) suspected as cause:
Oxaliplatin
    Indication: Oesophageal Carcinoma

Epirubicin
    Indication: Oesophageal Carcinoma

Cisplatin
    Indication: Oesophageal Carcinoma

Fluorouracil
    Indication: Oesophageal Carcinoma



Possible Epirubicin side effects in 38 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-25

Patient: 38 year old female

Reactions: Confusional State, Fistula, Vomiting, Nausea, Neurological Decompensation, Gastrointestinal Toxicity, Pyrexia, Grand MAL Convulsion, AIR Embolism, Brain Oedema, Intracranial Pressure Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Fluorouracil
    Dosage: continuous infusion

Therapeutic Radiopharmaceuticals
    Dosage: 50 gy given in 28 fraction

Oxaliplatin
    Dosage: 2-hour duration

Fluorouracil
    Dosage: continuous infusion

Fluorouracil
    Dosage: two cycles given, consolidation therapy

Cisplatin
    Dosage: two cycles given, consolidation therapy

Epirubicin

Oxaliplatin
    Dosage: 2-hour duration

Epirubicin



Possible Epirubicin side effects in 18 year old female

Reported by a health professional (non-physician/pharmacist) from India on 2011-10-18

Patient: 18 year old female

Reactions: Jaundice, Enterococcal Infection, Encephalopathy, Pyrexia, Ascites, Weight Increased, Hepatomegaly, Venoocclusive Liver Disease, Oedema Peripheral, Acute Hepatic Failure, Pleural Effusion, Tachypnoea, Gallbladder Disorder

Drug(s) suspected as cause:
Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Epirubicin
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Indication: Acute Lymphocytic Leukaemia

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014